查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018661

腦影像設備市場：按組件、技術、應用和最終用戶分類－2026-2032年全球市場預測

Brain Mapping Instruments Market by Component, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腦圖譜設備市場價值將達到 20.1 億美元，到 2026 年將成長到 23.1 億美元，到 2032 年將達到 51.5 億美元，複合年成長率為 14.33%。

主要市場統計數據
基準年 2025 20.1億美元
預計年份：2026年 23.1億美元
預測年份 2032 51.5億美元
複合年成長率 (%) 14.33%

全面實施不斷發展的腦影像設備生態系統，重點關注硬體、服務、軟體和最終用戶之間的互通性。

腦部影像設備在神經科學研究、臨床診斷和治療方法創新之間發揮著至關重要的作用。現代腦造影設備構成了一個由硬體、服務和軟體組成的複雜生態系統，這些組件協同工作，使臨床醫生和研究人員能夠可視化、量化和解讀不同時空尺度下的神經活動。隨著技術能力的不斷提升，腦影像設備的功能也日益超越單一設備，成為多模態整合、進階分析和協作工作流程的平台。

對技術整合、資料優先平台和服務主導模式進行詳細分析，這將重新定義腦圖譜設備在臨床和研究環境中的部署。

腦影像設備領域正經歷一場變革，小型化、即時分析以及人性化的設計理念的進步，拓展了神經資料收集的地點和方法。攜帶式無線腦電圖（EEG）系統使研究能夠在傳統實驗室環境之外進行，從而重新定義了可及性；而穿戴式式腦磁圖儀和新型近紅外線光譜（NIRS）技術則降低了長期和移動監測的門檻。這些硬體創新，結合雲端原生資料架構和邊緣分析技術，正引領情境神經科學的新時代，大規模地實現以病患和受試者為中心的工作流程。

對近期貿易政策和關稅變化如何影響腦部影像系統的供應鏈選擇、採購模式和服務優先事項進行詳細分析。

關稅體系和貿易政策的變化會對整個腦成像生態系統產生連鎖反應，影響關鍵組件和完整系統的供應、前置作業時間和成本結構。在對進口電子產品、感測器和成像子系統徵收關稅的情況下，製造商和採購團隊將被迫重新評估其供應鏈，並探索替代方案以降低進口成本增加的風險。這通常會加速關於供應商多元化、組件生產近岸化以及增加庫存緩衝的討論，以確保臨床和研究領域客戶的持續供應。

透過對組件、技術、應用和最終用戶進行有針對性的細分，可以揭示不同的採用因素和產品開發重點。

組件級細分揭示了硬體、服務和軟體領域不同的價值促進因素。在硬體投資方面，優先事項包括分析儀器的準確性和可靠性、電極和感測器的靈敏度和生物相容性，以及掃描儀的處理能力和影像保真度。諮詢、維護和培訓等服務是降低整體擁有成本 (TCO) 並縮短臨床人員和研究團隊掌握相關技術所需時間的關鍵差異化因素。軟體分為支援科學解讀的分析應用程式和確保安全、擴充性儲存以及滿足監管要求的審計追蹤的資料管理解決方案。

美洲、歐洲、中東和非洲以及亞太地區的競爭和採用趨勢影響著採購、製造和研究合作策略。

區域趨勢對腦部影像設備的研發、部署和商業化有顯著影響，每個主要區域都有其獨特的優勢和限制因素。在美洲，完善的臨床基礎設施以及集中的生物技術和製藥活動推動了對先進成像和電生理解決方案的需求，而充滿活力的研究生態系統則促進了轉化研究的快速合作。該地區還擁有成熟的製造群和創業投資網路，為創新提供支持，儘管公共醫療系統的採購週期可能較長。

企業策略和競爭優勢著重於模組化硬體、高階分析、整合服務以及促進長期機構部署的夥伴關係。

腦影像設備領域的企業正從多個方面進行差異化競爭，包括硬體模組化、先進的軟體以及廣泛的服務。領先的設備供應商專注於感測器性能、訊號保真度和符合人體工學的設計，以縮短設定時間並滿足不同研究人群的需求。同時，以軟體為核心的供應商則強調可復現的流程、可解釋的機器學習以及可互通的資料標準，從而促進與電子健康記錄和實驗室系統的整合。

為領導者提供具體建議，以加強供應鏈、投資數據平台並建立協作證據，從而實現永續的臨床部署。

產業領導者應優先考慮供應鏈韌性和模組化產品設計，以此作為抵禦地緣政治因素和關稅相關干擾的緩衝，從而確保為臨床和科研客戶提供持續服務。投資本地組裝和建立策略供應商合作夥伴關係可以減少前置作業時間波動，並保護機構免受突發成本衝擊。同時，模組化硬體架構支援分階段升級，延長設備使用壽命，並保護客戶的採購預算。

結合相關人員訪談、監管審查和技術測繪的嚴謹混合調查方法，可以得出可操作和可複製的見解。

本執行摘要的調查方法融合了定性和結構化的證據收集技術，以確保其穩健性和相關性。主要資訊來源包括對臨床醫生、首席研究員、採購負責人和設備工程師的深入訪談，以了解實際操作、挑戰和實施標準。此外，還對監管指南、技術標準和同行評審文獻進行了系統性回顧，以確定檢驗流程、安全注意事項和最佳方法實踐。

簡明結論總結了技術創新、服務模式和供應鏈動態之間的相互作用，這些相互作用正在塑造腦成像設備的未來。

腦造影設備的未來發展以技術的快速進步、服務模式的不斷演進以及供應鏈現狀的不斷變化為特徵，這些因素共同為相關人員帶來了機會和挑戰。在硬體、軟體和服務方面，成功越來越依賴提供可互通、以數據為中心的解決方案，這些方案需在遵守法規和臨床工作流程的前提下，為實際部署提供清晰的路徑。部署模式反映了高解析度成像方式與新興可攜式設備之間的相互作用，而最成功的策略是將這些成像方式整合到靈活且基於實證醫學的服務中。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：腦影像設備市場：依組件分類

  • 硬體
    • 分析設備
    • 電極和感測器
    • 掃描器
  • 服務
    • 諮詢
    • 維護和培訓
  • 軟體
    • 分析軟體
    • 資料管理軟體

第9章：腦部影像設備市場：依技術分類

  • EEG
    • 攜帶式腦電圖系統
    • 固定式腦電圖系統
    • 無線腦電圖系統
  • fMRI
    • 臨床功能性磁振造影
    • 用於研究的功能性磁振造影
  • MEG
    • 頭盔式MEG
    • 穿戴式 MEG
  • NIRS
    • 連續波近紅外光譜
    • 頻域近紅外光譜
    • 時域近紅外光譜
  • PET
    • 澱粉樣蛋白PET
    • FDG-PET
    • Tau

第10章：腦影像設備市場：依應用領域分類

  • 臨床
    • 神經病學
    • 腫瘤學
    • 精神病學
  • 研究
    • 學術研究
    • 認知神經科學
    • 藥物研究

第11章：腦影像設備市場：依最終用戶分類

  • 學術和研究機構
  • 醫院和診斷中心
  • 製藥和生物技術公司

第12章：腦造影設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：腦部影像設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：腦影像設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國腦部影像設備市場

第16章：中國腦圖譜設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Advanced Brain Monitoring, Inc.
  • ANT Neuro BV
  • Boston Scientific Corporation
  • Brain Products GmbH
  • Cadwell Industries, Inc.
  • CGX, A Cognionics Company
  • Compumedics Limited
  • Deymed Diagnostic
  • Elekta AB
  • General Electric Company
  • Koninklijke Philips NV
  • Magstim Company Limited
  • Medtronic plc
  • MEGIN Oy
  • Mrisym AG
  • Natus Medical Incorporated
  • Neuroelectrics Barcelona SL
  • Neurosoft LLC
  • NeuroWave Systems Inc.
  • Nihon Kohden Corporation
  • Rogue Research Inc.
  • Siemens Healthineers AG
  • York Instruments Ltd.
Product Code: MRR-2214614772D1

The Brain Mapping Instruments Market was valued at USD 2.01 billion in 2025 and is projected to grow to USD 2.31 billion in 2026, with a CAGR of 14.33%, reaching USD 5.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.01 billion
Estimated Year [2026] USD 2.31 billion
Forecast Year [2032] USD 5.15 billion
CAGR (%) 14.33%

A comprehensive introduction to the evolving ecosystem of brain mapping instruments addressing hardware, services, software, and end user interoperability

Brain mapping instruments occupy a pivotal role at the intersection of neuroscience research, clinical diagnostics, and therapeutic innovation. Contemporary instruments span a complex ecosystem of hardware, services, and software that together enable clinicians and researchers to visualize, quantify, and interpret neural activity across multiple spatial and temporal scales. As technological capabilities expand, instruments increasingly serve as platforms for multimodal integration, advanced analytics, and collaborative workflows that extend beyond isolated device deployment.

The hardware layer encompasses analysis equipment, electrodes and sensors, and scanning systems that must deliver precision, reliability, and compatibility with evolving analytical pipelines. Supporting services, including consulting and maintenance plus training programs, underpin successful adoption by ensuring operational continuity and maximized scientific yield. Software solutions range from analysis applications to data management systems designed to turn high-dimensional signals into reproducible, regulatory-grade outputs.

Across clinical and research contexts, user needs diverge but remain interconnected. Neurology, oncology, and psychiatry demand instruments that support diagnostic clarity and therapeutic monitoring, while academic research, cognitive neuroscience, and pharmaceutical research require flexible platforms for hypothesis-driven experimentation and translational studies. End users such as academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies each bring distinct procurement cycles, regulatory expectations, and data governance requirements.

Taken together, these dynamics underscore a shift from single-function devices toward interoperable, software-enabled systems that prioritize data integrity and lifecycle support. The introductory framing here sets the stage for deeper analysis of technology trajectories, supply chain pressures, regulatory considerations, and the strategic moves that will determine which solutions realize clinical and commercial impact.

An in-depth exploration of technological convergence, data-first platforms, and service-driven models reshaping brain mapping instrument adoption across clinical and research settings

The landscape for brain mapping instruments is undergoing transformative shifts driven by advances in miniaturization, real-time analytics, and human-centered design that expand where and how neural data can be collected. Portable and wireless EEG systems have redefined accessibility by enabling studies outside of traditional lab environments, while wearable magnetoencephalography and novel NIRS modalities are reducing barriers to longitudinal and ambulatory monitoring. These hardware innovations, paired with cloud-native data architectures and edge analytics, are ushering in a new era of contextual neuroscience where patient- and participant-centric workflows become feasible at scale.

Simultaneously, software is evolving from isolated analysis packages toward integrated platforms that combine advanced signal processing, machine learning, and secure data management. Analysis software now emphasizes reproducibility, provenance tracking, and regulatory readiness, and data management systems are adapting to stricter privacy expectations and federated learning models. As a result, services such as consulting, maintenance, and training increasingly focus on enabling institutions to operationalize complex instrument fleets and to extract longitudinal value from high-frequency data streams.

Another notable shift is the blurring of boundaries between clinical and research applications. Clinical fMRI and research fMRI workflows are converging through standardized protocols and interoperable data formats, while PET imaging subtypes are being integrated into multimodal studies that correlate metabolic signals with electrophysiological and hemodynamic measures. This convergence is fostering deeper collaborations between hospitals, academic centers, and pharmaceutical organizations, and it is accelerating the translation of experimental findings into diagnostic and therapeutic tools.

Finally, regulatory and reimbursement pressures are shaping product roadmaps. Manufacturers are prioritizing features that demonstrate clinical utility and that align with evidence frameworks used by payers and regulators. In parallel, supply chain resilience and localization strategies are becoming essential as geopolitical considerations influence sourcing and production decisions. Together, these shifts are redefining competitive advantage, moving it toward those organizations that combine device excellence with robust software ecosystems and end-to-end service capabilities.

A detailed analysis of how recent changes to trade policy and tariffs have altered supply chain choices, procurement models, and service priorities in brain mapping systems

Changes to tariff regimes and trade policy can ripple through the brain mapping ecosystem by affecting the availability, lead times, and cost profiles of critical components and finished systems. In scenarios where tariffs are applied to imported electronics, sensors, and imaging subsystems, manufacturers and procurement teams face pressure to reassess supply chains and to consider alternatives that reduce exposure to increased import costs. This often prompts accelerated conversations about supplier diversification, nearshoring of component production, and increased inventory buffering to ensure continuity for clinical and research customers.

The cumulative impact of tariff shifts in 2025 has been to elevate the strategic importance of manufacturing footprint and supplier relationships. Suppliers with vertically integrated capabilities or localized assembly facilities gain relative advantages because they can shield buyers from transit-related uncertainty and customs-related variability. Hospitals and research institutes, which typically operate on tight capital and procurement cycles, may adjust purchasing patterns to prioritize modular systems that allow incremental upgrades rather than full system replacements, thereby mitigating the price sensitivity introduced by higher import duties.

Tariffs also stimulate changes in contracting and service models. As capital expenditures become more complex to justify under higher component costs, many organizations will explore service-based procurement, extended leasing arrangements, and platform-as-a-service options to maintain access to leading-edge instrumentation without bearing the full upfront cost. Vendors that can provide comprehensive maintenance, training, and outcome-oriented service bundles are better positioned to retain institutional customers navigating tariff-driven budgetary constraints.

Lastly, regulatory and compliance efforts intersect with tariff-driven strategic choices. Institutions seeking to localize supply may encounter differing regulatory pathways and validation requirements across jurisdictions. Therefore, organizations must invest early in regulatory strategy and design controls to ensure that any changes in supplier or manufacturing location do not compromise clinical validity or research integrity. Overall, tariff dynamics are prompting a reorientation toward supply chain agility, service-led offerings, and localized validation efforts that collectively shape procurement and development priorities.

Targeted segmentation insights across components, technologies, applications, and end users that reveal differentiated adoption drivers and product development priorities

Component-level segmentation reveals divergent value drivers across hardware, services, and software. Hardware investments prioritize the precision and reliability of analysis equipment, the sensitivity and biocompatibility of electrodes and sensors, and the throughput and image fidelity of scanners. Services such as consulting and maintenance plus training become differentiators that reduce total cost of ownership and accelerate time-to-proficiency for clinical staff and research teams. Software divides into analysis applications that underpin scientific interpretation and data management solutions that ensure secure, scalable storage and regulatory-ready audit trails.

Technology segmentation clarifies where innovation and adoption pressures are most acute. EEG technologies, in their portable, stationary, and wireless forms, lead in democratizing data collection outside of traditional centers. fMRI retains its role as a high-resolution modality with distinct clinical and research workflows, while MEG is evolving through both helmet-based systems and emerging wearable formats that lower barriers to longitudinal monitoring. NIRS technologies-continuous wave, frequency domain, and time domain-offer complementary hemodynamic insights with varying trade-offs in spatial resolution and depth sensitivity. PET imaging, including amyloid PET, FDG-PET, and tau PET, continues to provide molecular specificity that intersects with neurodegenerative research and oncology applications.

Application segmentation differentiates clinical needs from research imperatives. Clinical deployments in neurology, oncology, and psychiatry demand validated, reproducible outputs that integrate into diagnostic pathways and therapeutic monitoring. Research applications across academic research, cognitive neuroscience, and pharmaceutical research require flexible platforms for experimental design, high-throughput data capture, and rigorous provenance for reproducibility. End-user segmentation underscores adoption dynamics: academic and research institutes prioritize flexibility and novel capabilities; hospitals and diagnostic centers emphasize reliability, regulatory compliance, and clinician workflows; and pharmaceutical and biotechnology companies focus on translational robustness and data interoperability for drug development pipelines.

Together, these segmentation lenses provide a framework for stakeholders to align product roadmaps, service offerings, and go-to-market strategies with the distinct needs of each technology, application, and user constituency.

Regional competitive and adoption dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, manufacturing, and research collaboration strategies

Regional dynamics exert a powerful influence on the development, adoption, and commercialization of brain mapping instruments, with distinct strengths and constraints characterizing each major geography. In the Americas, robust clinical infrastructure and concentrated biotech and pharmaceutical activity create demand for sophisticated imaging and electrophysiology solutions, while a vibrant research ecosystem fosters rapid translational collaborations. This region also features established manufacturing clusters and venture capital networks that support innovation, though procurement cycles in public health systems can be lengthy.

Europe, Middle East & Africa presents a diverse landscape where regulatory rigor and strong public healthcare systems drive a preference for validated clinical tools and integrated service offerings. Academic excellence across many European centers sustains deep research partnerships and high levels of methodological standardization. Meanwhile, emerging hubs within the broader region are increasingly important for localized manufacturing and as markets for cost-effective, robust instruments that support expanding diagnostic capabilities.

Asia-Pacific combines rapid adoption of portable and scalable technologies with growing in-region manufacturing capacity and government-backed initiatives that prioritize digital health and medical device innovation. High-volume healthcare markets and expanding research investment create opportunities for both cost-efficient device strategies and premium, data-rich platforms that support large-scale studies. Across regions, local policy, reimbursement frameworks, and talent availability influence how quickly new modalities move from early adoption to routine clinical use, and these factors should inform strategic decisions about product configuration, pricing, and post-sales service models.

Company strategies and competitive differentiators focused on modular hardware, advanced analytics, integrated services, and partnerships that drive long-term institutional adoption

Companies operating in the brain mapping instrument space are differentiating along multiple vectors, including hardware modularity, software sophistication, and depth of service offerings. Leading-edge device suppliers focus on sensor performance, signal fidelity, and ergonomic design to reduce setup time and to support diverse study populations. Concurrently, software-focused providers emphasize reproducible pipelines, explainable machine learning, and interoperable data standards that ease integration with electronic health records and laboratory systems.

Service providers are enhancing their propositions by bundling consulting, validation, and training with long-term maintenance contracts that align incentives around uptime and data quality. Alliances between device manufacturers and cloud or analytics firms are increasingly common, reflecting a move toward platform-centric business models. Startups frequently introduce disruptive hardware concepts or specialized analytics, and incumbent firms respond through targeted acquisitions, strategic partnerships, or by accelerating internal development of complementary capabilities.

Investor attention and corporate development activity tend to favor companies that demonstrate regulatory acumen and the ability to deliver evidence of clinical or translational value. Firms that can show robust data governance frameworks, an ecosystem of clinical partners, and flexible delivery models-ranging from capital sales to subscription services-are better positioned to capture multi-stakeholder value. Finally, operational excellence in manufacturing, supply chain resilience, and customer support often determines long-term customer retention, especially in clinical and diagnostic settings where continuity of service is paramount.

Actionable recommendations for leaders to strengthen supply chains, invest in data platforms, and build collaborative evidence pathways that enable sustained clinical adoption

Industry leaders should prioritize supply chain resilience and modular product design to buffer against geopolitical and tariff-related disruptions, thereby ensuring continuity of service for clinical and research customers. Investing in localized assembly or strategic supplier partnerships can reduce lead-time volatility and protect institutions from sudden cost shocks, while modular hardware architectures enable incremental upgrades that extend device lifecycles and protect customer procurement budgets.

Leaders must also accelerate investment in data management and analysis platforms that support regulatory traceability and interoperable workflows. Emphasizing reproducible analysis pipelines, provenance tracking, and privacy-preserving data strategies will facilitate clinical adoption and partnerships with pharmaceutical research programs. Coupled with targeted service offerings-such as on-site training, remote maintenance, and outcome-oriented consulting-these capabilities can convert transactional relationships into strategic long-term engagements.

Strategic collaboration with academic centers and clinical leaders is essential to generate evidence of clinical utility and to co-develop protocols that align with payer and regulatory expectations. Companies should explore flexible commercial models, including subscription-based access and outcome-tied pricing, to lower adoption barriers for cash-constrained institutions. Finally, a focused regulatory strategy that anticipates cross-jurisdictional validation requirements will reduce time to deployment and minimize rework, particularly for organizations planning to localize manufacturing or to enter new regional markets.

A rigorous mixed-methods research methodology combining stakeholder interviews, regulatory review, and technology mapping to produce actionable and reproducible insights

The research methodology underpinning this executive summary integrates qualitative and structured evidence-gathering techniques to ensure robustness and relevance. Primary inputs include in-depth interviews with clinicians, research directors, procurement officers, and device engineers to capture operational realities, pain points, and adoption criteria. These insights are supplemented by a systematic review of regulatory guidance, technical standards, and peer-reviewed literature to map validation pathways, safety considerations, and methodological best practices.

Analytical processes involve technology-by-application mapping to align device capabilities with clinical and research requirements, as well as supply chain mapping to identify sourcing risks and mitigation opportunities. Triangulation across perspectives-end users, manufacturers, and service providers-helps to validate conclusions and to ensure that recommendations reflect real-world constraints. Care is taken to document assumptions and to disclose limitations where evidence is emerging or where regional heterogeneity affects generalizability.

Data governance for the study prioritizes traceability and reproducibility, with structured protocols for coding interview themes and for archiving primary sources. Where quantitative inputs inform scenario interpretation, conservative and transparent approaches are applied to avoid overstating certainty. The overall approach aims to balance depth of insight with practical applicability for decision-makers across clinical, research, and commercial functions.

A concise conclusion summarizing the interplay of technological innovation, service models, and supply chain dynamics that will shape the future of brain mapping instruments

The trajectory of brain mapping instruments is characterized by rapid technological advances, evolving service models, and shifting supply chain realities that together create both opportunity and complexity for stakeholders. Across hardware, software, and services, success increasingly depends on delivering interoperable, data-centric solutions that respect regulatory and clinical workflows while providing clear pathways to operational deployment. Adoption patterns reflect the interplay between high-fidelity modalities and emerging portable formats, and the most successful strategies weave these modalities into flexible, evidence-backed offerings.

Regional and policy dynamics, including trade policy adjustments, have underscored the importance of supply chain agility, localized validation, and service-led commercial models. Organizations that proactively address these dimensions through modular design, investment in data management, and collaborative evidence generation will be better placed to meet the diverse needs of academic researchers, clinical teams, and pharmaceutical developers. In sum, the most resilient and impactful players will be those that blend technical excellence with robust support structures and strategic partnerships that accelerate translation from research to clinical utility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Mapping Instruments Market, by Component

  • 8.1. Hardware
    • 8.1.1. Analysis Equipment
    • 8.1.2. Electrodes & Sensors
    • 8.1.3. Scanners
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Maintenance & Training
  • 8.3. Software
    • 8.3.1. Analysis Software
    • 8.3.2. Data Management Software

9. Brain Mapping Instruments Market, by Technology

  • 9.1. EEG
    • 9.1.1. Portable EEG Systems
    • 9.1.2. Stationary EEG Systems
    • 9.1.3. Wireless EEG Systems
  • 9.2. fMRI
    • 9.2.1. Clinical fMRI
    • 9.2.2. Research fMRI
  • 9.3. MEG
    • 9.3.1. Helmet-Based MEG
    • 9.3.2. Wearable MEG
  • 9.4. NIRS
    • 9.4.1. Continuous Wave NIRS
    • 9.4.2. Frequency Domain NIRS
    • 9.4.3. Time Domain NIRS
  • 9.5. PET
    • 9.5.1. Amyloid PET
    • 9.5.2. FDG-PET
    • 9.5.3. Tau PET

10. Brain Mapping Instruments Market, by Application

  • 10.1. Clinical
    • 10.1.1. Neurology
    • 10.1.2. Oncology
    • 10.1.3. Psychiatry
  • 10.2. Research
    • 10.2.1. Academic Research
    • 10.2.2. Cognitive Neuroscience
    • 10.2.3. Pharmaceutical Research

11. Brain Mapping Instruments Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Hospitals & Diagnostic Centers
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Brain Mapping Instruments Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain Mapping Instruments Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain Mapping Instruments Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Brain Mapping Instruments Market

16. China Brain Mapping Instruments Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Advanced Brain Monitoring, Inc.
  • 17.7. ANT Neuro B.V.
  • 17.8. Boston Scientific Corporation
  • 17.9. Brain Products GmbH
  • 17.10. Cadwell Industries, Inc.
  • 17.11. CGX, A Cognionics Company
  • 17.12. Compumedics Limited
  • 17.13. Deymed Diagnostic
  • 17.14. Elekta AB
  • 17.15. General Electric Company
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Magstim Company Limited
  • 17.18. Medtronic plc
  • 17.19. MEGIN Oy
  • 17.20. Mrisym AG
  • 17.21. Natus Medical Incorporated
  • 17.22. Neuroelectrics Barcelona SL
  • 17.23. Neurosoft LLC
  • 17.24. NeuroWave Systems Inc.
  • 17.25. Nihon Kohden Corporation
  • 17.26. Rogue Research Inc.
  • 17.27. Siemens Healthineers AG
  • 17.28. York Instruments Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 272. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 274. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 275. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 277. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 278. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 279. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 281. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 283. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 284. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 317. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 319. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2032 (USD MILLION)
  • TABLE 322. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2032 (USD MILLION)
  • TABLE 323. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2032